Fabio Ynoe de Moraes: Proud to see Canadian-led research shaping the future of radiation oncology
Fabio Ynoe de Moraes, Associate Professor at Queen’s University, shared a post by André Gouveia, Clinical Assistant Professor of the Division of Radiation Oncology at The University of British Columbia – UBC, adding:
“Huge congratulations to André Gouveia and the entire team on this important publication.
This randomized trial is a major step forward in understanding the role of SBRT boost in high-risk and unfavorable-intermediate prostate cancer. Excellent work bringing patient-centered outcomes to the forefront. Proud to see Canadian-led research shaping the future of radiation oncology. Way to go Andre. Keep you excellent work.”
Quoting André Gouveia‘s post:
“I am pleased to share the link for the final publication of the PBS trial conducted at JCC and WFCC. Congratulations to the entire team, and thank you to the patients.”
Title: Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer
Authors: Andre Gouveia, Aruz Mesci, Naghmeh Isfahanian, Ian Dayes, Kimmen Quan, Mira Goldberg, Kara Lynne Schnarr, Himu Lukka, David Cuthbert, Abhiram Hallock, Georgia Douvi, Jim Wright, Anand Swaminath, Tom Chow, Kevin Diamond, George Hajdok, Lindsay Maharaj, Joycelyne Ewusie, Theodoros Tsakiridis
Read the Full Article.
More posts featuring Fabio Ynoe de Moraes.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023